[
    [
        {
            "time": "2020-10-28",
            "original_text": "Novo Nordisk A/S (NVO) Q3 2020 Earnings Call Transcript Analyst Report: Novo Nordisk A/S Novo Nordisk's (NVO) Q3 Earnings Beat Estimates, Sales Miss Novo Nordisk's operating profit increased by 6% in Danish kroner and by 7% at constant exchange rates (CER) in the first nine months of 2020",
            "features": {
                "keywords": [
                    "Q3 Earnings",
                    "Beat Estimates",
                    "Sales Miss",
                    "operating profit",
                    "increased",
                    "6%",
                    "7%",
                    "constant exchange rates"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Novo Nordisk A/S (NVO) Q3 2020 Earnings Call Transcript Analyst Report: Novo Nordisk A/S Novo Nordisk's (NVO) Q3 Earnings Beat Estimates, Sales Miss Novo Nordisk's operating profit increased by 6% in Danish kroner and by 7% at constant exchange rates (CER) in the first nine months of 2020",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]